1
|
Perfilyeva YV, Berdygulova ZA, Mashzhan AS, Zhigailov AV, Ostapchuk YO, Naizabayeva DA, Cherusheva AS, Bissenbay AO, Kuatbekova SA, Abdolla N, Nizkorodova AS, Kulemin MV, Shapiyeva ZZ, Sayakova ZZ, Perfilyeva AV, Akhmetollayev IA, Maltseva ER, Skiba YA, Mamadaliyev SM, Dmitrovskiy AM. Molecular and seroepidemiological investigation of Сoxiella burnetii and spotted fever group rickettsiae in the southern region of Kazakhstan. Ticks Tick Borne Dis 2023; 14:102240. [PMID: 37647811 DOI: 10.1016/j.ttbdis.2023.102240] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/09/2023] [Revised: 07/25/2023] [Accepted: 08/01/2023] [Indexed: 09/01/2023]
Abstract
Ticks are involved in the circulation of a number of human pathogens, including spotted fever group (SFG) Rickettsia spp. and Coxiella burnetii. Little is known about the occurrence of these microorganisms in the southern region of Kazakhstan. In 2018-2022, a total of 726 ticks were collected from bitten humans, livestock, and vegetation in four oblasts of the southern region of Kazakhstan and subjected to DNA extraction. The overall infection rate of Coxiella spp. and Rickettsia spp. in the ticks was 3.3% (24/726) and 69.9% (300/429), respectively. Phylogenetic analysis of ompA and gltA genes revealed the presence of three pathogenic SFG rickettsiae: Candidatus R. tarasevichiae, R. aeschlimannii and R. raoultii in ticks collected from bitten humans. In addition, Candidatus R. barbariae was detected in six Rhipicephalus turanicus ticks for the first time in Kazakhstan. To determine the seroprevalence of C. burnetii infection, we performed a serological analysis of samples collected from 656 domestic ruminants (cattle, sheep, and goats) in the region. Overall, 23.5% (154/656) of the animals tested were positive for IgG against C. burnetii. Seroprevalence at the herd level was 54% (28/52). Goats (43%; 12/28; odds ratio (OD) = 28.9, p < 0.05) and sheep (31.9%; 137/430; OD = 18.1, p < 0.05) had higher seroprevalence than cattle (2.5%; 5/198). Among the risk factors considered in this study, age (p = 0.003) and the oblast in which the animals were sampled (p = 0.049) were statistically associated with seropostivity for Q fever in sheep, according to the results of multivariate logistic regression analysis. Seroprevalence ranged from 0% to 55.5% in animals in different districts of the southern region of Kazakhstan. Active C. burnetii bacteremia was detected in four of 154 (2.6%) seropositive animals. The data obtained provide strong evidence of the presence of pathogenic rickettsiae and C. burnetii in the southern region of Kazakhstan and emphasize the need to improve epidemiological surveillance in the region.
Collapse
Affiliation(s)
- Yuliya V Perfilyeva
- Almaty Branch of the National Center for Biotechnology, Central Reference Laboratory, 14 Zhahanger St., Almaty 050054, Kazakhstan; M.A. Aitkhozhin Institute of Molecular Biology and Biochemistry, 86 Dosmukhamedov St., Almaty 050012, Kazakhstan
| | - Zhanna A Berdygulova
- Almaty Branch of the National Center for Biotechnology, Central Reference Laboratory, 14 Zhahanger St., Almaty 050054, Kazakhstan; Al-Farabi Kazakh National University, 71 Al-Farabi Avenue, Almaty 050040, Kazakhstan.
| | - Akzhigit S Mashzhan
- Almaty Branch of the National Center for Biotechnology, Central Reference Laboratory, 14 Zhahanger St., Almaty 050054, Kazakhstan; Al-Farabi Kazakh National University, 71 Al-Farabi Avenue, Almaty 050040, Kazakhstan.
| | - Andrey V Zhigailov
- Almaty Branch of the National Center for Biotechnology, Central Reference Laboratory, 14 Zhahanger St., Almaty 050054, Kazakhstan; M.A. Aitkhozhin Institute of Molecular Biology and Biochemistry, 86 Dosmukhamedov St., Almaty 050012, Kazakhstan
| | - Yekaterina O Ostapchuk
- Almaty Branch of the National Center for Biotechnology, Central Reference Laboratory, 14 Zhahanger St., Almaty 050054, Kazakhstan; M.A. Aitkhozhin Institute of Molecular Biology and Biochemistry, 86 Dosmukhamedov St., Almaty 050012, Kazakhstan
| | - Dinara A Naizabayeva
- Almaty Branch of the National Center for Biotechnology, Central Reference Laboratory, 14 Zhahanger St., Almaty 050054, Kazakhstan; Al-Farabi Kazakh National University, 71 Al-Farabi Avenue, Almaty 050040, Kazakhstan
| | - Alena S Cherusheva
- Almaty Branch of the National Center for Biotechnology, Central Reference Laboratory, 14 Zhahanger St., Almaty 050054, Kazakhstan
| | - Akerke O Bissenbay
- Almaty Branch of the National Center for Biotechnology, Central Reference Laboratory, 14 Zhahanger St., Almaty 050054, Kazakhstan; Al-Farabi Kazakh National University, 71 Al-Farabi Avenue, Almaty 050040, Kazakhstan
| | - Saltanat A Kuatbekova
- Almaty Branch of the National Center for Biotechnology, Central Reference Laboratory, 14 Zhahanger St., Almaty 050054, Kazakhstan
| | - Nurshat Abdolla
- Almaty Branch of the National Center for Biotechnology, Central Reference Laboratory, 14 Zhahanger St., Almaty 050054, Kazakhstan; M.A. Aitkhozhin Institute of Molecular Biology and Biochemistry, 86 Dosmukhamedov St., Almaty 050012, Kazakhstan
| | - Anna S Nizkorodova
- Almaty Branch of the National Center for Biotechnology, Central Reference Laboratory, 14 Zhahanger St., Almaty 050054, Kazakhstan; M.A. Aitkhozhin Institute of Molecular Biology and Biochemistry, 86 Dosmukhamedov St., Almaty 050012, Kazakhstan
| | - Maxim V Kulemin
- Anti-Plague Station, 114 Dulati St., Shymkent 160013, Kazakhstan
| | - Zhanna Zh Shapiyeva
- Scientific Practical Center of Sanitary-Epidemiological Expertise and Monitoring, 84 Auezov St., Almaty 050008, Kazakhstan
| | - Zaure Z Sayakova
- Almaty Branch of the National Center for Biotechnology, Central Reference Laboratory, 14 Zhahanger St., Almaty 050054, Kazakhstan; M. Aikimbayev National Scientific Center for Especially Dangerous Infections, 14 Zhahanger St., Almaty 050054, Kazakhstan
| | | | | | - Elina R Maltseva
- Almaty Branch of the National Center for Biotechnology, Central Reference Laboratory, 14 Zhahanger St., Almaty 050054, Kazakhstan; M.A. Aitkhozhin Institute of Molecular Biology and Biochemistry, 86 Dosmukhamedov St., Almaty 050012, Kazakhstan; Tethys Scientific Society, 9 Microdisctrict 1/72, Almaty 050036, Kazakhstan
| | - Yuriy A Skiba
- Almaty Branch of the National Center for Biotechnology, Central Reference Laboratory, 14 Zhahanger St., Almaty 050054, Kazakhstan; M.A. Aitkhozhin Institute of Molecular Biology and Biochemistry, 86 Dosmukhamedov St., Almaty 050012, Kazakhstan; Tethys Scientific Society, 9 Microdisctrict 1/72, Almaty 050036, Kazakhstan
| | - Seidigapbar M Mamadaliyev
- Almaty Branch of the National Center for Biotechnology, Central Reference Laboratory, 14 Zhahanger St., Almaty 050054, Kazakhstan
| | - Andrey M Dmitrovskiy
- Almaty Branch of the National Center for Biotechnology, Central Reference Laboratory, 14 Zhahanger St., Almaty 050054, Kazakhstan; M. Aikimbayev National Scientific Center for Especially Dangerous Infections, 14 Zhahanger St., Almaty 050054, Kazakhstan
| |
Collapse
|
3
|
Wagner E, Shin A, Tukhanova N, Turebekov N, Nurmakhanov T, Sutyagin V, Berdibekov A, Maikanov N, Lezdinsh I, Shapiyeva Z, Shevtsov A, Freimüller K, Peintner L, Ehrhardt C, Essbauer S. First Indications of Omsk Haemorrhagic Fever Virus beyond Russia. Viruses 2022; 14:v14040754. [PMID: 35458484 PMCID: PMC9030969 DOI: 10.3390/v14040754] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/11/2022] [Revised: 04/01/2022] [Accepted: 04/02/2022] [Indexed: 01/27/2023] Open
Abstract
Omsk haemorrhagic fever virus (OHFV) is the agent leading to Omsk haemorrhagic fever (OHF), a viral disease currently only known in Western Siberia in Russia. The symptoms include fever, headache, nausea, muscle pain, cough and haemorrhages. The transmission cycle of OHFV is complex. Tick bites or contact with infected small mammals are the main source of infection. The Republic of Kazakhstan is adjacent to the endemic areas of OHFV in Russia and febrile diseases with haemorrhages occur throughout the country—often with unclear aetiology. In this study, we examined human cerebrospinal fluid samples of patients with suspected meningitis or meningoencephalitis with unknown origins for the presence of OHFV RNA. Further, reservoir hosts such as rodents and ticks from four Kazakhstan regions were screened for OHFV RNA to clarify if this virus could be the causative agent for many undiagnosed cases of febrile diseases in humans in Kazakhstan. Out of 130 cerebrospinal fluid samples, two patients (1.53%) originating from Almaty city were positive for OHFV RNA. Screening of tick samples revealed positive pools from different areas in the Akmola region. Of the caught rodents, 1.1% out of 621 were positive for OHFV at four trapping areas from the West Kazakhstan region. In this paper, we present a broad investigation of the spread of OHFV in Kazakhstan in human cerebrospinal fluid samples, rodents and ticks. Our study shows for the first time that OHFV can not only be found in the area of Western Siberia in Russia, but can also be detected up to 1.600 km away in the Almaty region in patients and natural foci.
Collapse
Affiliation(s)
- Edith Wagner
- Section of Experimental Virology, Institute of Medical Microbiology, Jena University Hospital, 07743 Jena, Germany; (E.W.); (C.E.)
- Department of Virology and Intracellular Agents, Bundeswehr Institute of Microbiology, 80937 Munich, Germany; (K.F.); (S.E.)
| | - Anna Shin
- Center for International Health, University Hospital, LMU, 80336 Munich, Germany; (A.S.); (N.T.)
- Aikimbayev’s National Scientific Center for Especially Dangerous Infections, Almaty 050000, Kazakhstan; (N.T.); (T.N.)
| | - Nur Tukhanova
- Center for International Health, University Hospital, LMU, 80336 Munich, Germany; (A.S.); (N.T.)
- Aikimbayev’s National Scientific Center for Especially Dangerous Infections, Almaty 050000, Kazakhstan; (N.T.); (T.N.)
| | - Nurkeldi Turebekov
- Aikimbayev’s National Scientific Center for Especially Dangerous Infections, Almaty 050000, Kazakhstan; (N.T.); (T.N.)
| | - Talgat Nurmakhanov
- Aikimbayev’s National Scientific Center for Especially Dangerous Infections, Almaty 050000, Kazakhstan; (N.T.); (T.N.)
| | - Vitaliy Sutyagin
- Antiplague Station Taldykorgan, Branch Aikimbayev’s National Scientific Center for Especially Dangerous Infections, Taldykorgan 040000, Kazakhstan; (V.S.); (A.B.); (I.L.)
| | - Almas Berdibekov
- Antiplague Station Taldykorgan, Branch Aikimbayev’s National Scientific Center for Especially Dangerous Infections, Taldykorgan 040000, Kazakhstan; (V.S.); (A.B.); (I.L.)
| | - Nurbek Maikanov
- Oral Antiplague Station, Branch Aikimbayev’s National Scientific Center for Especially Dangerous Infections, Oral 090002, Kazakhstan;
| | - Ilmars Lezdinsh
- Antiplague Station Taldykorgan, Branch Aikimbayev’s National Scientific Center for Especially Dangerous Infections, Taldykorgan 040000, Kazakhstan; (V.S.); (A.B.); (I.L.)
| | - Zhanna Shapiyeva
- Scientific Practical Center of Sanitary Epidemiological Expertise and Monitoring, Almaty 050000, Kazakhstan;
| | | | - Klaus Freimüller
- Department of Virology and Intracellular Agents, Bundeswehr Institute of Microbiology, 80937 Munich, Germany; (K.F.); (S.E.)
| | - Lukas Peintner
- Department of Virology and Intracellular Agents, Bundeswehr Institute of Microbiology, 80937 Munich, Germany; (K.F.); (S.E.)
- Correspondence: ; Tel.: +49-89-992-692-3813
| | - Christina Ehrhardt
- Section of Experimental Virology, Institute of Medical Microbiology, Jena University Hospital, 07743 Jena, Germany; (E.W.); (C.E.)
| | - Sandra Essbauer
- Department of Virology and Intracellular Agents, Bundeswehr Institute of Microbiology, 80937 Munich, Germany; (K.F.); (S.E.)
| |
Collapse
|
4
|
Peintner L, Wagner E, Shin A, Tukhanova N, Turebekov N, Abdiyeva K, Spaiser O, Serebrennikova Y, Tintrup E, Dmitrovskiy A, Zhalmagambetova A, Frey S, Essbauer SS. Eight Years of Collaboration on Biosafety and Biosecurity Issues Between Kazakhstan and Germany as Part of the German Biosecurity Programme and the G7 Global Partnership Against the Spread of Weapons and Materials of Mass Destruction. Front Public Health 2021; 9:649393. [PMID: 34434910 PMCID: PMC8381731 DOI: 10.3389/fpubh.2021.649393] [Citation(s) in RCA: 6] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/04/2021] [Accepted: 07/06/2021] [Indexed: 11/30/2022] Open
Abstract
In 2013, the German Federal Foreign Office launched the German Biosecurity Programme with the aim to minimise risks associated with biological substances and pathogens. In this context, the German-Kazakh Network for Biosafety and Biosecurity was established in 2013 and constitutes a successful collaboration between Kazakh and German biomedical organisations, under the co-management of the Bundeswehr Institute of Microbiology (IMB), and the Deutsche Gesellschaft für Internationale Zusammenarbeit (GIZ) GmbH. Ever since then, a network of scientists, stake holders and policymakers has been established, aiming to work on highly pathogenic, potential biological warfare agents with the focus on biosafety and biosecurity, surveillance, detection and diagnostics, networking and awareness raising of these agents in Kazakhstan. Over the past 8 years, the project members trained four PhD candidates, organised over 30 workshops and trainings with more than 250 participants and conducted more than 5,000 PCR assays and 5,000 serological analyses for surveillance. A great success was the description of new endemic areas for Orthohantaviruses, the mixture of two Crimean-Congo haemorrhagic fever virus genetic clusters, new foci and genetic information on tick-borne encephalitis virus and rickettsiae in Kazakh oblasts. The latter even led to the description of two new genogroups. Furthermore, joint contributions to international conferences were made. In this report, we summarise the evolution of the German-Kazakh Network for Biosafety and Biosecurity and critically reflect on the strengths and possible weaknesses. We were able to establish a viable network of biosafety and biosecurity shareholders and to accomplish the aims of the German Biosecurity Programme to lower biosecurity risks by increased awareness, improved detection and diagnostic methods and surveillance. Further, we reflect on forthcoming aspects to lead this interstate endeavour into a sustainable future.
Collapse
Affiliation(s)
- Lukas Peintner
- Department of Virology and Intracellular Agents, German Centre for Infection Research, Munich Partner Site, Bundeswehr Institute of Microbiology, Munich, Germany
| | - Edith Wagner
- Department of Virology and Intracellular Agents, German Centre for Infection Research, Munich Partner Site, Bundeswehr Institute of Microbiology, Munich, Germany.,Section of Experimental Virology, Institute of Medical Microbiology, Jena University Hospital, Jena, Germany
| | - Anna Shin
- Central Reference Laboratory, M. Aikimbaev National Scientific Center for Especially Dangerous Infections, Almaty, Kazakhstan.,Center for International Health, Ludwig-Maximilians-University, Munich, Germany
| | - Nur Tukhanova
- Central Reference Laboratory, M. Aikimbaev National Scientific Center for Especially Dangerous Infections, Almaty, Kazakhstan.,Center for International Health, Ludwig-Maximilians-University, Munich, Germany
| | - Nurkeldi Turebekov
- Central Reference Laboratory, M. Aikimbaev National Scientific Center for Especially Dangerous Infections, Almaty, Kazakhstan
| | - Karlygash Abdiyeva
- Central Reference Laboratory, M. Aikimbaev National Scientific Center for Especially Dangerous Infections, Almaty, Kazakhstan
| | - Olga Spaiser
- Deutsche Gesellschaft für Internationale Zusammenarbeit GmbH, Berlin, Germany
| | | | - Erik Tintrup
- Division OR12 "Chemical and Biological Weapons, Disarmament, G7 Global Partnership", German Federal Foreign Office, Berlin, Germany
| | - Andrey Dmitrovskiy
- Central Reference Laboratory, M. Aikimbaev National Scientific Center for Especially Dangerous Infections, Almaty, Kazakhstan
| | - Aliya Zhalmagambetova
- Deutsche Gesellschaft für Internationale Zusammenarbeit GmbH, Berlin, Germany.,Deutsche Gesellschaft für Internationale Zusammenarbeit GmbH, Almaty, Kazakhstan
| | - Stefan Frey
- Department of Virology and Intracellular Agents, German Centre for Infection Research, Munich Partner Site, Bundeswehr Institute of Microbiology, Munich, Germany.,Bundeswehr Research Institute for Protective Technologies and CBRN Protection, Munster, Germany
| | - Sandra Simone Essbauer
- Department of Virology and Intracellular Agents, German Centre for Infection Research, Munich Partner Site, Bundeswehr Institute of Microbiology, Munich, Germany
| |
Collapse
|